Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19

被引：17

作者：

Lim, Sarah ^{[1
]}

Tignanelli, Christopher J. ^{[2
]}

Hoertel, Nicolas ^{[3
]}

Boulware, David R. ^{[4
]}

Usher, Michael G. ^{[4
]}

机构：

[1] Minnesota Dept Hlth, 625 North Robert St, St Paul, MN 55155 USA

[2] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA

[3] Univ Paris Cite, Hop Corentin Celton, AP HP, DMU Psychiat & Addictol,INSERM,U1266,Inst Psychia, Paris, France

[4] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 08期

关键词：

nirmatrelvir; ritonavir; COVID-19; contraindications; Palovid;

D O I：

10.1093/ofid/ofac389

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness.

引用

页数：4

共 50 条

[1] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
LeBras, Marlys
Crawley, Alex
Legge, Marc
Takaya, Satchan
Lee, Stephen
Regier, Loren
CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
[2] Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
Hoertel, Nicolas
Boulware, David R.
Sanchez-Rico, Marina
Burgun, Anita
Limosin, Frederic
JAMA NETWORK OPEN, 2022, 5 (11) : e2242140
[3] Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019 (COVID-19)
Ganatra, Sarju
Dani, Sourbha S.
Ahmad, Javaria
Kumar, Ashish
Shah, Jui
Abraham, George M.
McQuillen, Daniel P.
Wachter, Robert M.
Sax, Paul E.
CLINICAL INFECTIOUS DISEASES, 2023, 76 (04) : 563 - 572
[4] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
Focosi, Daniele
Nicastri, Emanuele
ANNALS OF INTERNAL MEDICINE, 2023, 176 (10)
[5] Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
Chhiba, Krishan D.
Patel, Gayatri B.
Vu, Thanh Huyen T.
Chen, Michael M.
Guo, Amina
Kudlaty, Elizabeth
Mai, Quan
Yeh, Chen
Muhammad, Lutfiyya N.
Harris, Kathleen E.
Bochner, Bruce S.
Grammer, Leslie C.
Greenberger, Paul A.
Kalhan, Ravi
Kuang, Fei Li
Saltoun, Carol A.
Schleimer, Robert P.
Stevens, Whitney W.
Peters, Anju T.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (02) : 307 - +
[6] Nirmatrelvir for Nonhospitalized Adults with Covid-19
Chen, Brian S.
Hung, Cheng-Hsien
Wei, James C. C.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 474 - 474
[7] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 Response
Wan, Eric Yuk Fai
Yan, Vincent Ka Chun
Mok, Anna Hoi Ying
Wong, Ian Chi Kei
Chan, Esther Wai Yin
ANNALS OF INTERNAL MEDICINE, 2023, 176 (10) : eL230265
[8] Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19
Lu, Jiayue
Cai, Hong
Hao, Yujun
Lin, Zhang
Liu, Shang
Zhan, Yaping
Ding, Li
Huang, Meilan
Li, Zhenyuan
Xu, Lan
Yan, Xiujuan
Yang, Li
Zhang, He
Zhang, Wei
Zhao, Li
Zhao, Junli
Wang, Ting
Gu, Leyi
FRONTIERS IN PHARMACOLOGY, 2023, 14
[9] Nirmatrelvir for Nonhospitalized Adults with Covid-19 Reply
Hammond, Jennifer
Bao, Weihang
Simon-Campos, Abraham
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 475 - 476
[10] Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19
Gao, Yuan
Luo, Zujin
Ren, Shan
Duan, Zhonghui
Han, Ying
Liu, Huihang
Gao, Ziwen
Zhang, Xinyu
Hu, Zhongjie
Ma, Yingmin
JOURNAL OF INFECTION, 2023, 86 (06) : E158 - E160

← 1 2 3 4 5 →